Literature DB >> 11405217

Intracellular bacteria as targets and carriers for vaccination.

H Mollenkopf1, G Dietrich, S H Kaufmann.   

Abstract

In this review we discuss intracellular bacteria as targets and carriers for vaccines. For clarity and ease of comprehension, we focus on three microbes, Mycobacterium tuberculosis, Listeria monocytogenes and Salmonella, with an emphasis on tuberculosis, one of the leading causes of death from infectious disease. Novel vaccination strategies against these pathogens are currently being considered. One approach favors the use of live attenuated vaccines and vaccine carrier strains thereof, either for heterologous antigen presentation or DNA vaccine delivery. This strategy includes both the improvement of attenuated vaccine strains as well as the 'de novo' generation of attenuated variants of virulent pathogens. An alternative strategy relies on the application of subunit immunizations, either as nucleic acid vaccines or protein antigens of the pathogen. Finally, we present a short summary of the vaccination strategies against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11405217     DOI: 10.1515/BC.2001.066

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  13 in total

1.  Complexes of streptavidin-fused antigens with biotinylated antibodies targeting receptors on dendritic cell surface: a novel tool for induction of specific T-cell immune responses.

Authors:  Ondrej Stanek; Irena Linhartova; Laleh Majlessi; Claude Leclerc; Peter Sebo
Journal:  Mol Biotechnol       Date:  2012-07       Impact factor: 2.695

2.  Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus.

Authors:  Matthew J Giacalone; Juan C Zapata; Neil L Berkley; Roger A Sabbadini; Yen-Lin Chu; Maria S Salvato; Kathleen L McGuire
Journal:  Vaccine       Date:  2006-12-26       Impact factor: 3.641

3.  A platelet-mediated system for shuttling blood-borne bacteria to CD8α+ dendritic cells depends on glycoprotein GPIb and complement C3.

Authors:  Admar Verschoor; Michael Neuenhahn; Alexander A Navarini; Patricia Graef; Ann Plaumann; Amelie Seidlmeier; Bernhard Nieswandt; Steffen Massberg; Rolf M Zinkernagel; Hans Hengartner; Dirk H Busch
Journal:  Nat Immunol       Date:  2011-10-30       Impact factor: 25.606

4.  Rapid method for the construction of Salmonella enterica Serovar Typhimurium vaccine carrier strains.

Authors:  Mohamed I Husseiny; Michael Hensel
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

5.  Down-regulation of key virulence factors makes the Salmonella enterica serovar Typhimurium rfaH mutant a promising live-attenuated vaccine candidate.

Authors:  Gábor Nagy; Vittoria Danino; Ulrich Dobrindt; Mark Pallen; Roy Chaudhuri; Levente Emödy; Jay C Hinton; Jörg Hacker
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

6.  Comparison of a regulated delayed antigen synthesis system with in vivo-inducible promoters for antigen delivery by live attenuated Salmonella vaccines.

Authors:  Shifeng Wang; Yuhua Li; Huoying Shi; Wei Sun; Kenneth L Roland; Roy Curtiss
Journal:  Infect Immun       Date:  2010-12-06       Impact factor: 3.441

7.  Evaluation of Salmonella enterica type III secretion system effector proteins as carriers for heterologous vaccine antigens.

Authors:  Wael Abdel Halim Hegazy; Xin Xu; Leonid Metelitsa; Michael Hensel
Journal:  Infect Immun       Date:  2012-01-17       Impact factor: 3.441

8.  Characterization of Salmonella enterica derivatives harboring defined aroC and Salmonella pathogenicity island 2 type III secretion system (ssaV) mutations by immunization of healthy volunteers.

Authors:  Zoë Hindle; Steven N Chatfield; Jo Phillimore; Matthew Bentley; Julie Johnson; Catherine A Cosgrove; Marjan Ghaem-Maghami; Amy Sexton; Mohammad Khan; Frank R Brennan; Paul Everest; Tao Wu; Derek Pickard; David W Holden; Gordon Dougan; George E Griffin; Deborah House; Joseph D Santangelo; Shahid A Khan; Jaqueline E Shea; Robert G Feldman; David J M Lewis
Journal:  Infect Immun       Date:  2002-07       Impact factor: 3.441

9.  Construction and characterization of bivalent Shigella flexneri 2a vaccine strains SC608(pCFAI) and SC608(pCFAI/LTB) that express antigens from enterotoxigenic Escherichia coli.

Authors:  Ryan T Ranallo; C Piyumi Fonseka; Fred Cassels; Jay Srinivasan; Malabi M Venkatesan
Journal:  Infect Immun       Date:  2005-01       Impact factor: 3.441

Review 10.  Pathogenic bacteria as vaccine vectors: teaching old bugs new tricks.

Authors:  Heather A Carleton
Journal:  Yale J Biol Med       Date:  2010-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.